Q
QuantAbundanceAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

30,601 signal articles · 135 in last 24h · 155,365 total before filter · latest 2h ago
135last 24h
852last 7d
146● bullish (7d)
90● bearish (7d)
214publishers
AllMacro192Earnings102M&A125Regulatory20Product22Analyst19
✕ clear all filterssentiment: neutralSentiment:bullishneutralbearishshow all (incl. clickbait)
Moderna (MRNA): Buy, Sell, or Hold Post Q2 Earnings?
StockStory40d agoneutral
Moderna (MRNA): Buy, Sell, or Hold Post Q2 Earnings?

What a fantastic six months it’s been for Moderna. Shares of the company have skyrocketed 44.2%, hitting $63.36. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.

Zoom (ZM): Buy, Sell, or Hold Post Q1 Earnings?
StockStory40d agoneutral
Zoom (ZM): Buy, Sell, or Hold Post Q1 Earnings?

Over the past six months, Zoom has been a great trade, beating the S&P 500 by 10.4%. Its stock price has climbed to $109.49, representing a healthy 23.5% increase. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.

JPMorgan Raises S&P 500 Target to 8,000 as Earnings and AI Growth Strengthen Outlook
InvestorsHub40d agoneutral
JPMorgan Raises S&P 500 Target to 8,000 as Earnings and AI Growth Strengthen Outlook

JPMorgan has increased its 2026 S&P 500 price target to 8,000 from 7,800, pointing to an exceptionally strong second-quarter earnings season and growing evidence that massive artificial intelligence investments are translating into stronger business performance. The bank also raised its earnings forecasts for both 2026 and 2027, although elevated interest rates, geopolitical risks and heavy capital-market supply are keeping its valuation assumptions in check.